Pharmacologic therapy of arrhythmias

Gerald Naccarelli; R. L. Rinkenberger; A. H. Doughtery; E. Berns; J. R. Crandell

doi:10.1080/21548331.1988.11703565

Pharmacologic therapy of arrhythmias

Gerald Naccarelli, R. L. Rinkenberger, A. H. Doughtery, E. Berns, J. R. Crandell

Research output: Contribution to journal › Review article › peer-review

Abstract

Regardless of the arrhythmia treated or the antiarrhythymic drug selected, proper evaluation and appropriate testing should be performed in control and treated states. During therapy, monitoring of ECG intervals, blood levels, subjective toxicity, and end-organ toxicity must be tailored for the individual patient and for the antiarrhythmic drug selected.

Original language	English (US)
Pages (from-to)	183-210
Number of pages	28
Journal	Hospital Practice
Volume	23
Issue number	10
DOIs	https://doi.org/10.1080/21548331.1988.11703565
State	Published - 1988

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

10.1080/21548331.1988.11703565

Cite this

@article{242b9b345cc74ec8a310cd33a823cb22,

title = "Pharmacologic therapy of arrhythmias",

abstract = "Regardless of the arrhythmia treated or the antiarrhythymic drug selected, proper evaluation and appropriate testing should be performed in control and treated states. During therapy, monitoring of ECG intervals, blood levels, subjective toxicity, and end-organ toxicity must be tailored for the individual patient and for the antiarrhythmic drug selected.",

author = "Gerald Naccarelli and Rinkenberger, {R. L.} and Doughtery, {A. H.} and E. Berns and Crandell, {J. R.}",

year = "1988",

doi = "10.1080/21548331.1988.11703565",

language = "English (US)",

volume = "23",

pages = "183--210",

journal = "Hospital Practice",

issn = "8750-2836",

publisher = "Informa UK Ltd",

number = "10",

}

TY - JOUR

T1 - Pharmacologic therapy of arrhythmias

AU - Naccarelli, Gerald

AU - Rinkenberger, R. L.

AU - Doughtery, A. H.

AU - Berns, E.

AU - Crandell, J. R.

PY - 1988

Y1 - 1988

N2 - Regardless of the arrhythmia treated or the antiarrhythymic drug selected, proper evaluation and appropriate testing should be performed in control and treated states. During therapy, monitoring of ECG intervals, blood levels, subjective toxicity, and end-organ toxicity must be tailored for the individual patient and for the antiarrhythmic drug selected.

AB - Regardless of the arrhythmia treated or the antiarrhythymic drug selected, proper evaluation and appropriate testing should be performed in control and treated states. During therapy, monitoring of ECG intervals, blood levels, subjective toxicity, and end-organ toxicity must be tailored for the individual patient and for the antiarrhythmic drug selected.

UR - http://www.scopus.com/inward/record.url?scp=0023797117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023797117&partnerID=8YFLogxK

U2 - 10.1080/21548331.1988.11703565

DO - 10.1080/21548331.1988.11703565

M3 - Review article

C2 - 3139691

AN - SCOPUS:0023797117

SN - 8750-2836

VL - 23

SP - 183

EP - 210

JO - Hospital Practice

JF - Hospital Practice

IS - 10

ER -

Pharmacologic therapy of arrhythmias

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this